Sophie Lane
Overview
Explore the profile of Sophie Lane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cahierc R, Debost-Legrand A, Lane S, Rouzaire M, Bonnin M, Delabaere A, et al.
Gynecol Obstet Fertil Senol
. 2023 Aug;
51(10):448-454.
PMID: 37634804
Objectives: The Shock Index (SI) is used in emergency medicine to assess the severity of active bleeding and in the postpartum context for postpartum haemorrhage (PPH). We investigated the diagnostic...
2.
Kowal J, Arrigoni E, Lane S
Bio Protoc
. 2021 Mar;
10(20):e3786.
PMID: 33659441
Identifying microscopic mycorrhizal fungal structures in roots, , hyphae, vesicles and arbuscules, requires root staining procedures that are often time consuming and involves chemicals known to present health risks from...
3.
Sadanand S, Das J, Chung A, Schoen M, Lane S, Suscovich T, et al.
AIDS
. 2017 Dec;
32(4):443-450.
PMID: 29239894
Objective: Given the emerging appreciation for the role of antibody-dependent effector functions and IgG subclass distribution among spontaneous controllers of HIV, we sought to determine whether antibody-associated features diverged in...
4.
Kukalev A, Ng Y, Ju L, Saidi A, Lane S, Mondragon A, et al.
Cereb Cortex
. 2017 Apr;
27(1):11-23.
PMID: 28365778
In mitotic cells, the cyclin-dependent kinase (CDK) subunit protein CKS1 regulates S phase entry by mediating degradation of the CDK inhibitor p27. Although mature neurons lack mitotic CDKs, we found...
5.
Asmal M, Lane S, Tian M, Nickel G, Venner C, Dirk B, et al.
Virology
. 2016 Oct;
499:298-312.
PMID: 27723488
For studies on vaccines and therapies for HIV disease, SIV-HIV chimeric viruses harboring the HIV-1 env gene (SHIVenv) remain the best virus in non-human primate models. However, there are still...
6.
Chung A, Ghebremichael M, Robinson H, Brown E, Choi I, Lane S, et al.
Sci Transl Med
. 2014 Mar;
6(228):228ra38.
PMID: 24648341
The human phase 2B RV144 ALVAC-HIV vCP1521/AIDSVAX B/E vaccine trial, held in Thailand, resulted in an estimated 31.2% efficacy against HIV infection. By contrast, vaccination with VAX003 (consisting of only...
7.
Sun Y, Asmal M, Lane S, Permar S, Schmidt S, Mascola J, et al.
J Virol
. 2011 May;
85(14):6906-12.
PMID: 21593181
With the recent demonstration in the RV144 Thai trial that a vaccine regimen that does not elicit neutralizing antibodies or cytotoxic T lymphocytes may confer protection against human immunodeficiency virus...
8.
Asmal M, Sun Y, Lane S, Yeh W, Schmidt S, Mascola J, et al.
J Virol
. 2011 Apr;
85(11):5465-75.
PMID: 21450829
Antibody-dependent cell-mediated viral inhibition (ADCVI) is an attractive target for vaccination because it takes advantage of both the anamnestic properties of an adaptive immune response and the rapid early response...
9.
Holic R, Kukalev A, Lane S, Andress E, Lau I, Yu C, et al.
Mol Cell Biol
. 2010 Jun;
30(15):3894-901.
PMID: 20516216
Cyclin-dependent kinase-associated protein 1 (Cks1) is involved in the control of the transcription of a subset of genes in addition to its role in controlling the cell cycle in the...